Amrize (AMRZ) Q2 2026 earnings review
Record Volumes Collide With an Inflationary Wall
Amrize posted a robust 8.6% revenue jump in Q2, but underlying profitability is Reversing course under the weight of severe cost inflation. While the top line benefited from surging demand in data centers and infrastructure, Adjusted EBITDA margins dropped 80 bps to 28.2%. The pain was most acute in the Building Envelope segment, where margins collapsed 350 bps despite volume growth. This price-cost mismatch forced a sharp divergence in FY26 guidance: management raised the revenue outlook on strong demand but slashed the Adjusted EBITDA target by ~$100M at the midpoint, proving that current pricing actions are failing to offset rising freight, diesel, and raw material expenses.
🐂 Bull Case
The company is executing flawlessly on commercial opportunities, capitalizing on over 300 planned data center campuses in North America (positioned to serve 90% of them) and vast IIJA infrastructure funding. This drove 5.0% cement and 6.5% aggregates volume growth.
The ASPIRE synergy program delivered $29M in Q2 savings and remains on track for $80M this year. Furthermore, the PB Materials acquisition exceeded expectations, and the subsequent Rapid Redi-Mix purchase positions the Texas network for significant scale.
🐻 Bear Case
Oil-driven inflation (diesel, freight, raw materials) wiped out $75M of EBITDA in the quarter. Management admits that price realization is lagging behind these input costs, effectively capping near-term profit growth.
The company had to revise historical statements due to a $78M understatement of deferred warranty revenues. While deemed 'immaterial' to prior reports, restating financials less than a year after the spin-off raises yellow flags regarding internal controls.
⚖️ Verdict: 🔴
Bearish. A top-line beat cannot mask a core earnings guidance cut. The inability to price ahead of inflation breaks the margin expansion narrative established during the spin-off. Until the price-cost dynamic turns positive in the second half, the stock's fundamental momentum is stalled.
Key Themes
Cost Inflation Crushes Margin Expansion
The defining theme of Q2 was Decelerating profitability against Accelerating sales. Despite generating an $89M EBITDA benefit from volume and $16M from price, soaring costs for raw materials, freight, and diesel wiped out $75M of profit. This forced management to abandon their original FY26 EBITDA guidance.
Building Envelope Margin Collapse
A severe red flag emerged in the Building Envelope segment. While revenue grew an impressive 9.4% (above the company average) driven by a rebound in residential roofing volumes, Segment Adjusted EBITDA fell 5.2%. The margin violently compressed by 350 bps to 22.6%, demonstrating that taking on new volume came at the direct expense of profitability due to raw material inflation.
Infrastructure & Data Centers Propel Building Materials
Building Materials continues to be the operational workhorse, posting 8.2% revenue growth and protecting margins better than its sister segment (down only 100 bps to 32.4%). Constant-currency aggregates pricing rose 4.0%, proving that highly localized, heavy materials retain better pricing power in an inflationary environment, fueled by non-discretionary federal infrastructure spending and localized data center builds.
Aggressive Capital Deployment via M&A
Amrize is heavily leaning into geographic consolidation. Following the successful integration of PB Materials (which contributed $54M to Q2 revenue and exceeded expectations in West Texas), the company acquired Rapid Redi-Mix in July. This bolt-on deal immediately provides modern batch plants and a mixer fleet that creates high-margin synergies with Amrize's Midlothian cement plant expansion in the Dallas-Fort Worth metro.
Accounting Revision on Warranty Deferrals
The company disclosed a $78M historical understatement of deferred revenue associated with extended warranties for acquisitions (Duro-Last, Malarkey). While Amrize concluded the errors were historically immaterial, correcting them in Q2 2026 would have materially skewed the current quarter. Post-spinoff accounting adjustments often signal weak integration of acquired legacy IT and control systems.
Other KPIs
Decelerating. Cash burn worsened compared to -$860M in H1 2025. This was heavily driven by a massive increase in capital expenditures ($511M vs $419M) to fund growth initiatives, as well as a $939M seasonal build in accounts receivable. While highly seasonal (cash generation skews heavily to H2), the intensified first-half burn requires monitoring.
Amrize aggressively executed its new capital allocation framework in Q2, paying out $305M in dividends (including the $0.44 special dividend) and quickly deploying $197M toward its newly authorized $1B share buyback program. This highlights management's confidence in H2 cash flow generation despite the EBITDA guidance cut.
Stable compared to the end of Q1, but up from 1.1x at the end of FY25. The ratio reflects the seasonal peak in working capital needs and aggressive capital return execution. Total liquidity remains strong at approximately $4.0B.
Guidance
Accelerating. Management raised the target from the previous $12.29 - $12.52B range. The midpoint ($12.6B) implies roughly 6.6% YoY growth versus FY25. This reflects stronger-than-expected volume traction in commercial roofing, residential roofing (now expected up high single digits), and resilient aggregate demand.
Decelerating. Management cut this range from the initial $3.25 - $3.34B guidance. The revised midpoint ($3.15B) implies just 4.8% YoY growth, effectively breaking the narrative that EBITDA growth would outpace revenue growth via ASPIRE synergies. Management explicitly pointed to the timing difference between realizing price hikes and immediate oil-driven cost inflation.
Accelerating. Upgraded from the prior expectation of 'flat' residential roofing volumes. However, as Q2 margins showed, this volume is currently coming with poor incremental profitability.
Key Questions
Price-Cost Inflection Timing
You noted that H2 price-cost will improve as July and August price increases phase in. Given the severity of the Q2 cost hit, exactly what month do you expect the Building Envelope segment to cross back into positive price-over-cost territory?
Controls Behind the Restatement
Regarding the $78M understatement of deferred warranty revenue, what specific internal control failures allowed this to persist since the 2022/2023 acquisitions, and what independent reviews are being conducted on the rest of the legacy IT systems?
Margin vs. Volume Trade-off
Building Envelope saw above-market volume growth but a 350 bps margin contraction. Are you sacrificing price to take market share in residential roofing, or is this purely a function of raw material inflation hitting faster than contractual price pass-throughs?